Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Children may be given a total of 1 to 5 mg over a period of 2 or more weeks in doses of 100 mcg, then 30 to 50 mcg every 4 weeks for maintenance
These doses assume a 2 mg/mL concentration vial using an insulin syringe marked in units
Safety Profile Based on Available Preclinical safety studies have not identified significant adverse effects from BPC-157 administration in animal models at doses substantially higher than those used in supplementation
Kidney and cardiovascular outcomes SURPASS-4 kidney composite HR 0.58, slower eGFR decline (-1.4 vs -3.6 mL/min/1.73m2/yr), UACR -6.8% vs +36.9%
While this effect appears to be related to the magnitude and rapidity of glucose lowering rather than a direct effect of the medication itself, patients with a history of diabetic retinopathy should undergo careful ophthalmologic evaluation before and during treatment, and the potential risks should be weighed against the expected benefits of improved glycemic control
US$ 25.85
US$ 27.93
US$ 20.80
US$ 29.25
US$ 21.15
US$ 24.53
US$ 24.42
US$ 28.89
US$ 29.61
US$ 22.39
US$ 22.22
US$ 23.01
US$ 29.50
US$ 22.89
